Alnylam Pharmaceuticals reported $15.62B in Market Capitalization this May of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Agios Pharmaceuticals AGIO:US $ 1.78B 0.94B
Arrowhead Research ARWR:US $ 4.86B 2.07B
Avrobio Inc AVRO:US $ 0.06B 0.11B
Bluebird Bio BLUE:US $ 0.7B 0.59B
IONIS PHARMACEUT IONS:US $ 4.3B 0.44B
Mirati Therapeutics MRTX:US $ 4.56B 3.54B
Regulus Therapeutics RGLS:US $ 0.04B 0.02B
Sangamo Biosciences SGMO:US $ 0.85B 0.24B
Sanofi SNY:US 129.35B 2.11B
Xencor XNCR:US $ 1.58B 0.76B